Wire Stories
Promising disease modifying approach to Duchenne muscular dystrophy with Neu-REFIX® Beta 1,3-1,6 glucan* from Japan; the first such clinical report.
Safety, Fibrosis control and increased muscle strength reported clinically. TOKYO–(BUSINESS WIRE)–#duchenne—Duchenne Muscular Dystrophy (DMD) patients showed signs of disease progress slowing down,...